198 related articles for article (PubMed ID: 2984936)
1. Uterine sarcoma: analysis of prognostic variables in 71 cases.
Wheelock JB; Krebs HB; Schneider V; Goplerud DR
Am J Obstet Gynecol; 1985 Apr; 151(8):1016-22. PubMed ID: 2984936
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
3. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of patients with sarcoma of the uterus].
Bokhman IaV; Urmancheeva AF
Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071
[TBL] [Abstract][Full Text] [Related]
5. Uterine sarcoma: an analysis of 74 cases.
Covens AL; Nisker JA; Chapman WB; Allen HH
Am J Obstet Gynecol; 1987 Feb; 156(2):370-4. PubMed ID: 3030107
[TBL] [Abstract][Full Text] [Related]
6. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract][Full Text] [Related]
7. A clinical and pathologic study of 34 sarcomas of the uterus.
Kenda R; De Palo G; Andreola S; Bandieramonte G; Lupi G; Musumeci R
Tumori; 1981 Aug; 67(4):341-8. PubMed ID: 7314262
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcoma: a clinicopathological study of 93 cases.
González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
10. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
11. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998.
Livi L; Andreopoulou E; Shah N; Paiar F; Blake P; Judson I; Harmer C
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):261-8. PubMed ID: 15214650
[TBL] [Abstract][Full Text] [Related]
12. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
[TBL] [Abstract][Full Text] [Related]
13. [Sarcomas of the uterus: morphological criteria and clinical course (author's transl)].
Eberl M; Pfleiderer A; Teufel G; Bachmann F
Pathol Res Pract; 1980 Oct; 169(2):165-72. PubMed ID: 7443573
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcomas: a clinicopathologic study, 1965-1981.
Marchese MJ; Liskow AS; Crum CP; McCaffrey RM; Frick HC
Gynecol Oncol; 1984 Jul; 18(3):299-312. PubMed ID: 6086468
[TBL] [Abstract][Full Text] [Related]
15. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
16. Prognostic features of sarcomas and mixed tumors of the endometrium.
Peters WA; Kumar NB; Fleming WP; Morley GW
Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
[TBL] [Abstract][Full Text] [Related]
17. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcoma in the south of Israel: study of 36 cases.
Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
J Surg Oncol; 1997 Jan; 64(1):55-62. PubMed ID: 9040802
[TBL] [Abstract][Full Text] [Related]
19. Uterine sarcoma: prognostic factors and treatment evaluation.
Naaman Y; Shveiky D; Ben-Shachar I; Shushan A; Mejia-Gomez J; Benshushan A
Isr Med Assoc J; 2011 Feb; 13(2):76-9. PubMed ID: 21443030
[TBL] [Abstract][Full Text] [Related]
20. Uterine sarcomas: a clinicopathologic study.
Chiara S; Foglia G; Odicino F; Graziani A; Conte PF; Ragni N; Fulcheri E; Pescetto G
Oncology; 1988; 45(6):428-33. PubMed ID: 3186152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
